Table 1: Secondary outcome measures of the study before treatment (I1), 2–4 weeks after the last treatment session (I2), and 2 months after I2 (I3).

Outcome measuresI1Before/after treatmentI2I3
12345678910

FIQ and checkupXXX
VASXXXXXXXXXXXXX
SF 36XXX
SESXXX
MDBFXX

FIQ: fibromyalgia impact questionnaire, VAS: pain (visual analogue scale), SF 36: quality of life, SES: pain perception scale, MDBF: multidimensional mood state questionnaire.